Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Open in API
Filings indexed 252 across all filing types
Latest filing 2020-05-01 Capital/Financing Update
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a proposed private placement offering by Ovation Science Inc. It details the terms of the offering, including the number of units, price, warrants, use of proceeds, and broker commissions. There is no financial statement, quarterly or annual report, or detailed financial analysis included. The document is short (2507 characters) and serves as an announcement of a financing activity. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-05-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a proposed private placement offering by Ovation Science Inc. It details the number of units to be offered, pricing, warrants, use of proceeds, and broker commissions. There is no financial statement or detailed financial analysis present. The document is short (2504 characters) and serves as an announcement of a financing activity rather than a full financial report. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-05-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2019. The document is a certification letter and does not contain actual financial data or the full annual report itself. It explicitly states it is a certification and includes disclaimers about controls and procedures. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports. The document length is short (3088 characters), consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-04-30 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'INDEPENDENT AUDITOR'S REPORT' and contains an auditor's opinion on the consolidated financial statements of Ovation Science Inc. for the years ended December 31, 2019 and 2018. It includes detailed financial statements such as the consolidated statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows, along with notes to the financial statements. The presence of an auditor's report with an opinion on the financial statements and detailed financial data indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and audit details, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2019
2020-04-30 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to reporting issuers and participation fees, including a management certification by an officer (Chief Financial Officer) certifying the accuracy of the information submitted to the Alberta Securities Commission. The content focuses on market values, securities outstanding, and fee calculations rather than financial statements or detailed financial performance. The presence of a management certification and the nature of the form indicate this is a regulatory filing related to compliance and fee reporting, not a full financial report or earnings release. The document length is moderate and contains no substantive financial statements or analysis. Therefore, it fits best under Regulatory Filings (RNS) as a certification and compliance document submitted to a regulatory body.
2020-04-30 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management Discussion & Analysis For the years ended December 31, 2019 and 2018' and contains detailed narrative about the company's business, regulatory environment, and forward-looking statements. It references preparation in accordance with National Instrument 51-102 and IFRS standards, and discusses financial and operational aspects in depth. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content matches the typical Management Discussion and Analysis (MD&A) section found in financial filings, which provides management's detailed explanation of financial results, business trends, and outlook. Therefore, the document fits the Management Reports (MDA) category.
2020-04-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.